Summary & Overview
HCPCS J7999: Compounded Drug, Not Otherwise Classified
HCPCS Level II code J7999 represents a catch-all classification for compounded drugs not otherwise classified. It matters nationally because compounded pharmaceuticals are commonly used when commercially available products do not meet a patient’s clinical needs, and reimbursement pathways for these items can vary across major payers. Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will learn what J7999 covers, typical sites of service where compounded drugs are provided, and the clinical context for using compounded preparations. The publication also summarizes payer coverage patterns and common billing considerations, clarifies where data is not available in the input, and highlights coding contexts that affect reimbursement and claims adjudication. This summary provides a national perspective useful for billing staff, revenue cycle managers, and clinical teams who handle compounded pharmaceuticals in outpatient and ambulatory settings.
Billing Code Overview
HCPCS Level II code J7999 denotes a compounded drug, not otherwise classified. This code is used to report compounded medications that do not have a specific HCPCS Level II code assigned. The service type associated with this code is administration or provision of a compounded pharmaceutical product. The typical site of service for items billed with this code includes outpatient infusion centers, physician offices, hospital outpatient departments, and other ambulatory care settings where compounded medications are furnished to patients.
Clinical & Coding Specifications
Clinical Context
A patient with a chronic dermatologic condition (for example, severe eczema with documented allergic reactions to standard topical corticosteroid vehicles) presents to a dermatologist. Standard commercial topical therapies have failed or caused intolerance. The dermatologist prescribes a customized compounded topical formulation containing a specific concentration of corticosteroid combined with a preservative-free base and added emollient to reduce sensitivity. The compounded medication is prepared by a licensed pharmacy specializing in sterile or nonsterile compounding depending on formulation. The clinical workflow: the clinician documents the medical necessity, writes a prescription specifying strength, base, and any exclusions (e.g., preservative-free), and includes relevant ICD-10 diagnosis codes. The pharmacy compounds the drug, assigns a National Drug Code (if applicable) or internal lot number, and dispenses with directions. Billing uses the HCPCS Level II code J7999 for a compounded drug not otherwise classified. Claims may include appropriate modifiers to indicate circumstances (for example, 22 for increased procedural services when additional documentation supports extra work) and may require submission of the compound formula and ingredient list for medical review. Typical sites of service include outpatient clinics, dermatology offices, infusion/ambulatory pharmacies, and specialty compounding pharmacies. Patients commonly return for follow-up visits to assess efficacy and tolerability and to adjust concentration or vehicle as needed.
Coding Specifications
| Modifier | Description | When to Use |
|---|